Literature DB >> 3873786

Preliminary investigations on the pharmacological control of catabolin-induced cartilage destruction in vitro.

K D Rainsford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873786     DOI: 10.1007/bf01999648

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


× No keyword cloud information.
  5 in total

Review 1.  Antirheumatic drug concentrations in human synovial fluid and synovial tissue. Observations on extravascular pharmacokinetics.

Authors:  W J Wallis; P A Simkin
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

2.  Heberden oration 1978. Recent studies on the control of joint damage: the contribution of the Strangeways Research Laboratory.

Authors:  J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

3.  The effect of synovial tissue on the breakdown of articular cartilage in organ culture.

Authors:  H B Fell; R W Jubb
Journal:  Arthritis Rheum       Date:  1977 Sep-Oct

4.  Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro.

Authors:  J Saklatvala; V A Curry; S J Sarsfield
Journal:  Biochem J       Date:  1983-11-01       Impact factor: 3.857

5.  Effects of antirheumatoid drugs on the production and action of porcine catabolin.

Authors:  H Sheppeard; L M Pilsworth; B Hazleman; J T Dingle
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

  5 in total
  3 in total

1.  The effect of anti-rheumatic drugs on factors from porcine synovium inducing chondrocyte mediated cartilage degradation.

Authors:  K G Couchman; H Sheppeard
Journal:  Agents Actions       Date:  1986-10

2.  Inhibition by cartilage and bone marrow fractions of cartilage resorption induced by interleukin-1 and tumour necrosis factor.

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1988-02

3.  Oxicams: relative safety and anti-injury effects in rats.

Authors:  M W Whitehouse
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.